Explore
13D/13G Activist Filings
118,703 resultsSome filings may show "N/A" for ticker if the subject is a private fund, SPAC, or unlisted security.
| Filed ↓ | Ticker | Company | Filer | Form | % Owned | Shares |
|---|---|---|---|---|---|---|
| Feb 20, 2026 | BTDR | BITDEER TECHNOLOGIES GROUP | Tether Global Investments Fund, S.I.C.A.F., S.A. | 13D/A | 20.1% | 38.4M |
| Feb 20, 2026 | IMUX | Immunic, Inc. | Vivo Opportunity Fund Holdings, L.P. | 13G | 10.0% | 29.1M |
| Feb 20, 2026 | CNVS | Cineverse Corp. | CORSAIR CAPITAL PARTNERS LP | 13G | 6.8% | 1.5M |
| Feb 20, 2026 | SONM | DNA X, Inc. | DNA Holdings Venture Inc. | 13D | 19.9% | 223K |
| Feb 20, 2026 | RPRX | Royalty Pharma plc | R & H Trust Co. (Guernsey) Limited | 13D/A | 5.7% | 24.2M |
| Feb 20, 2026 | NTST | NETSTREIT Corp. | Millennium Management LLC | 13G | 5.4% | 5.2M |
| Feb 20, 2026 | RSG | Republic Services, Inc. | Cascade Investment, L.L.C. | 13D/A | 35.6% | 109.8M |
| Feb 20, 2026 | LIMN | Liminatus Pharma, Inc. | Mitchell P. Kopin | 13G | 5.0% | 2.1M |
| Feb 20, 2026 | SOHO | Sotherly Hotels Inc. | KW Kingfisher LLC | 13D | 100.0% | 100 |
| Feb 20, 2026 | ACOG | Alpha Cognition Inc. | Opaleye Management Inc. | 13G/A | 10.4% | 2.3M |
| Feb 20, 2026 | N/A | KAZIA THERAPEUTICS LTD | Chernett Jorey | 13G/A | 12.5% | 1.4M |
| Feb 20, 2026 | HUN | Huntsman Corporation | Peter R. Huntsman | 13D | 5.1% | 8.9M |
| Feb 20, 2026 | GBTG | Global Business Travel Group, Inc. | Apollo Principal Holdings A GP, Ltd. | 13D/A | 4.4% | 22.9M |
| Feb 20, 2026 | WBX | WALLBOX NV | KARIEGA VENTURES, S.L. | 13G/A | 6.3% | 1.1M |
| Feb 20, 2026 | NERV | Minerva Neurosciences, Inc. | Coastlands Capital LP | 13G | 10.0% | 4.6M |
| Feb 20, 2026 | BCAR | D. Boral Acquisition I Corp. | Sculptor Capital LP | 13G | 5.7% | 1.8M |
| Feb 20, 2026 | ASTI | Ascent Solar Technologies, Inc. | Ryan Taylor | 13G | 9.8% | 754K |
| Feb 20, 2026 | N/A | United Acquisition Corp. I | RP Investment Advisors LP | 13G | 9.1% | 925K |
| Feb 20, 2026 | N/A | Spartacus Acquisition Corp. II | RP Investment Advisors LP | 13G | 5.4% | 1.3M |
| Feb 20, 2026 | SEER | Seer, Inc. | Radoff Family Foundation | 13D | 0.9% | 500K |
| Feb 20, 2026 | MATH | Metalpha Technology Holding Ltd | LSQ Investment Fund SPC - Disruptive Opportunity Fund II SP | 13G/A | 8.6% | 3.7M |
| Feb 20, 2026 | N/A | ZenaTech, Inc. | GG Mars Capital, Inc. | 13D/A | 100.0% | 4.0M |
| Feb 20, 2026 | N/A | enVVeno Medical Corp | Braeden Lichti | 13D | 5.0% | 33K |
| Feb 20, 2026 | N/A | enVVeno Medical Corp | Northstrive Fund II LP | 13D | 3.1% | 20K |
| Feb 20, 2026 | TYRA | Tyra Biosciences, Inc. | Farallon Capital Partners, L.P. | 13G | 0.9% | 505K |
| Feb 20, 2026 | NNDM | Nano Dimension Ltd. | Oramed Pharmaceuticals Inc. | 13D/A | 5.2% | 10.9M |
| Feb 20, 2026 | N/A | Spartacus Acquisition Corp. II | Harraden Circle Investments, LLC | 13G | 6.5% | 1.5M |
| Feb 20, 2026 | CORZ | Core Scientific, Inc. | Two Seas Capital LP | 13D/A | 6.7% | 20.7M |
| Feb 20, 2026 | N/A | United Acquisition Corp. I | United Acquisition SPAC LLC | 13D | 27.3% | 3.9M |
| Feb 20, 2026 | N/A | SCI Engineered Materials, Inc. | Charles Kohnen | 13D | 8.1% | 364K |
| Feb 20, 2026 | HIPO | Hippo Holdings Inc. | Lennar Corporation | 13D/A | 0.0% | 0 |
| Feb 20, 2026 | FNKO | Funko, Inc. | Fund 1 Investments, LLC | 13D | 10.0% | 5.5M |
| Feb 19, 2026 | N/A | Our Bond, Inc. | Ascent Partners Fund LLC | 13G | 10.0% | 1.7M |
| Feb 19, 2026 | SIMA | SIM ACQUISITION CORP. I | SIM Sponsor 1 LLC | 13G/A | 24.7% | 7.5M |
| Feb 19, 2026 | ACOG | Alpha Cognition Inc. | Funicular Funds, LP | 13G | 5.1% | 1.1M |
| Feb 19, 2026 | N/A | Power REIT | Bradley and Daytona Railway and Land Co. LLC | 13G | 5.0% | 17K |
| Feb 19, 2026 | FORR | Forrester Research, Inc. | Portolan Capital Management, LLC | 13G | 6.1% | 1.2M |
| Feb 19, 2026 | N/A | XFLH Capital Corp | Feis Equities LLC | 13G | 5.8% | 585K |
| Feb 19, 2026 | INV | Innventure, Inc. | Ascent Capital Partners LLC | 13D/A | 6.7% | 5.3M |
| Feb 19, 2026 | MET | MetLife, Inc. | Board of Directors of MetLife, Inc., as an entity | 13D/A | 16.2% | 105.4M |
| Feb 19, 2026 | PHR | Phreesia, Inc. | Pale Fire Capital SICAV a.s. | 13D | 9.2% | 5.6M |
| Feb 19, 2026 | EXPI | EXP WORLD HOLDINGS, INC. | Penny Sanford | 13D/A | 16.5% | 26.7M |
| Feb 19, 2026 | EXPI | EXP WORLD HOLDINGS, INC. | Glenn Sanford | 13D/A | 25.7% | 41.7M |
| Feb 19, 2026 | QTTB | Q32 Bio Inc. | Point72 Asset Management, L.P. | 13G | 9.9% | 2.1M |
| Feb 19, 2026 | N/A | ZenaTech, Inc. | GG Mars Capital, Inc. | 13D/A | 100.0% | 3.1M |
| Feb 19, 2026 | NMRA | Neumora Therapeutics, Inc. | Invus Public Equities, L.P. | 13G | 4.9% | 8.2M |
| Feb 19, 2026 | TVA | Texas Ventures Acquisition III Corp | Yorkville Acquisition Sponsor II, LLC | 13D/A | 25.0% | 7.5M |
| Feb 19, 2026 | EVMN | Evommune, Inc. | LSP 7 Cooperatieve U.A. | 13D/A | 14.7% | 5.3M |
| Feb 19, 2026 | HOFT | Hooker Furnishings Corporation | Global Value Investment Corp. | 13D/A | 5.2% | 560K |
| Feb 19, 2026 | IMUX | IMMUNIC, INC. | Soleus Capital Master Fund, L.P. | 13G | 5.5% | 6.8M |